A detailed history of Invictus Private Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Invictus Private Wealth, LLC holds 421 shares of LLY stock, worth $323,226. This represents 0.03% of its overall portfolio holdings.

Number of Shares
421
Previous 405 3.95%
Holding current value
$323,226
Previous $367 Million 1.72%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$772.14 - $960.02 $12,354 - $15,360
16 Added 3.95%
421 $373 Million
Q2 2024

Aug 02, 2024

SELL
$724.87 - $909.04 $3,624 - $4,545
-5 Reduced 1.22%
405 $367 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $9,475 - $12,676
-16 Reduced 3.76%
410 $319 Million
Q3 2023

Oct 04, 2023

SELL
$434.7 - $599.3 $7,824 - $10,787
-18 Reduced 4.05%
426 $229 Million
Q2 2023

Aug 24, 2023

BUY
$350.74 - $468.98 $155,728 - $208,227
444 New
444 $208 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Invictus Private Wealth, LLC Portfolio

Follow Invictus Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invictus Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invictus Private Wealth, LLC with notifications on news.